Indian Biosimilars and Vaccines at Crossroads–Replicating the Success of Pharmagenerics

Indian Biosimilars and Vaccines at Crossroads–Replicating the Success of Pharmagenerics

Background: The global pharma sector is fast shifting from generics to biologics and biosimilars with the first approval in Europe in 2006 followed by US approval in 2015. In the form of Hepatitis B vaccine, India saw its first recombinant biologics approval in 2000. Around 20% of generic medication...

Full description

Bibliographic Details
Main Authors: Sunita Panda, Puneet Kumar Singh, Snehasish Mishra, Sagnik Mitra, Priyabrata Pattnaik, Sanjib Das Adhikary, Ranjan K. Mohapatra
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Vaccines
Subjects:
Indian biosimilars
pharmagenerics
healthcare scenario
human resource
visionary perspective
Online Access:https://www.mdpi.com/2076-393X/11/1/110

Internet

https://www.mdpi.com/2076-393X/11/1/110

Similar Items